Elon Musk’s brain-implant company Neuralink on Thursday said it had received the US Food and Drug Administration’s (FDA) approval to launch its first-in-human clinical study.
On at least four occasions since 2019, Musk has predicted that his medical device company would soon start human trials of a brain implant to treat intractable conditions such as paralysis and blindness.
Yet the company, founded in 2016, did not seek permission from the FDA until early 2022 — and the agency rejected the application, seven current and former employees told Reuters in March.
Source link